Product List

Chemco is expanding its pharmaceutical manufacturing capabilities through an upcoming GMP unit dedicated to advanced and penultimate intermediates. The facility is being developed to support customer programs linked to APIs including Acalabrutinib, Ambrisentan, Apixaban, Apremilast, Canagliflozin, Chlorthalidone, Dapagliflozin, Sotagliflozin, Doxofylline, Empagliflozin, Etoricoxib, Famotidine, Ibrutinib, Mirabegron, Tazemetostat, Ticagrelor and Praziquantel.

The new unit will support process development, technology transfer, scale-up and commercial manufacturing, with a focus on reliable execution, long-term supply and customer-specific intermediate programs.

We are thrilled to share our Keynote 2025/26 address by Mr. Samir Mody, Director of Chemco Group. He highlights our journey of innovation, recent advancements i

Established in 1976, Chemco is an Indian manufacturer with deep expertise in nitration and specialty chemistry. We are now advancing into KSMs, advanced and penultimate pharmaceutical intermediates, supporting customers from development and technology transfer through scale-up and long-term commercial manufacturing.

Upcoming GMP Unit - December 2026.